CM
PL icon

Crestline Management’s Planet Labs PL Stock Holding History

Crestline Management’s Portfolio PL Stock Details PL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-250,000
Closed -$2.48M – 257
2021
Q3 		$2.48M Buy
+250,000
New +$2.48M 0.23% 96

Other funds holding PL

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $602M AUM 165.22% 1-Year Est. Return
SCC
Spring Creek Capital Wichita, Kansas $2.53B AUM 19.59% 1-Year Est. Return
DCI
Data Collective II Palo Alto, California $8.44M AUM 11.7% 1-Year Est. Return
FFIM
Founders Fund IV Management San Francisco, California $1.21M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
EPL
EDBI Pte Ltd Singapore $94.4M AUM 32.71% 1-Year Est. Return
RTM
Rizvi Traverse Management West Palm Beach, Florida $63.4M AUM 53.91% 1-Year Est. Return

Crestline Management's PL Position: Q4 2021 in Review

Crestline Management sold out of Planet Labs (PL) in Q4 2021, closing a stake of 250,000 shares — an estimated $2.48M sold.

Crestline Management first reported a position in PL in Q3 2021 and held it in 1 quarter. The position peaked at $2.48M in Q3 2021. 115 funds tracked by Wall St. Rank hold PL as of Q4 2021.

  • Crestline Management reported no remaining Planet Labs position as of Q4 2021 after selling out during the quarter.
  • Crestline Management sold 250,000 Planet Labs shares in Q4 2021, an estimated $2.48M.
  • Crestline Management first reported a position in Planet Labs in Q3 2021 and held it in 1 quarter.
  • Crestline Management's Planet Labs position peaked at $2.48M in Q3 2021.
  • 115 funds tracked by Wall St. Rank held Planet Labs as of Q4 2021.

Based on Crestline Management's 13F filing for Q4 2021, filed 14 Feb 2022.